deoxycytidine has been researched along with Prostatic Neoplasms, Castration-Resistant in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Jeong, KC; Kwon, WA; Lee, SJ; Seo, HK | 1 |
Argyros, O; Fokas, D; Karampelas, T; Kolios, G; Liapakis, G; Millar, RP; Morgan, K; Pappas, C; Sayyad, N; Spyridaki, K; Tamvakopoulos, C; Tzakos, AG | 1 |
Chang, YJ; Huang, CY; Huang, MT; Lin, FY; Luo, SD; Tai, CJ; Uyanga, B | 1 |
Argyros, O; Fokas, D; Karampelas, T; Skavatsou, E; Tamvakopoulos, C | 1 |
4 other study(ies) available for deoxycytidine and Prostatic Neoplasms, Castration-Resistant
Article | Year |
---|---|
Docetaxel-resistant prostate cancer cells become sensitive to gemcitabine due to the upregulation of ABCB1.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Deoxycytidine; Docetaxel; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Male; Mice; Mice, Nude; PC-3 Cells; Prostatic Neoplasms, Castration-Resistant; RNA, Small Interfering; Transcriptome; Transfection; Up-Regulation; Xenograft Model Antitumor Assays | 2020 |
GnRH-Gemcitabine conjugates for the treatment of androgen-independent prostate cancer: pharmacokinetic enhancements combined with targeted drug delivery.
Topics: Animals; Cell Proliferation; Deoxycytidine; Drug Delivery Systems; Gemcitabine; Gonadotropin-Releasing Hormone; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, SCID; Molecular Structure; Prostatic Neoplasms, Castration-Resistant; Receptors, LHRH; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2014 |
Maspin mediates the gemcitabine sensitivity of hormone-independent prostate cancer.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Cell Line, Tumor; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Serpins; Signal Transduction | 2016 |
Gemcitabine Based Peptide Conjugate with Improved Metabolic Properties and Dual Mode of Efficacy.
Topics: Animals; Deoxycytidine; Female; Gemcitabine; Humans; Male; Mice; Mice, Inbred C57BL; Peptides; Prodrugs; Prostatic Neoplasms, Castration-Resistant; Rats, Wistar; Receptors, LHRH; Tissue Distribution; Tumor Cells, Cultured | 2017 |